Statin therapy in patients with high and very high cardiovascular risk: an optimal approach

Abstract

This article discusses the problems of adequate therapy for dys-lipidemia in patients with high and very high cardiovascular risk in clinical practice. Updated Russian and European guidelines for the treatment of dyslipidemia pick out five categories of cardiovascular risk and clarify goals of prevention and treatment of atherosclerosis. The data of most significant clinical studies on rosuvastatin, highlighting its high lipid-lowering efficacy, the effect on the progression of atherosclerosis and the prognosis in patients with cardiovascular disease, are presented.

Keywords

• дислипидемия
• очень высокий сердечно-сосудистый риск
• интенсивная статинотерапия
• атеросклероз
• розува-статин